Telling women as part of mammography screening that they have dense breasts may have unintended effects

Leaves some women anxious and confused about their breast health and may increase demand on health services, say researchers Recommendations introduced in Australia and being considered in the UK to tell women if they have dense breasts as part of their screening results may have unintended effects and increase demand on ...

2025-12-04T10:10:13+00:004 December 2025|Press release, The BMJ|

Missing first screening appointment linked to higher risk of breast cancer death

25/11/2025: Expressions of concern placed on research paper and linked editorial on attendance at first breast screening appointment and breast cancer death Expressions of concern have been placed on the research paper and linked editorial after concerns that messaging in key areas of these articles may not be sufficiently supported ...

2025-11-25T13:39:59+00:0025 September 2025|Press release, The BMJ|

Bout of cystitis may signal presence of urogenital cancers in middle-aged adults

Risks especially high within 3 months of infection but last for several years Men seem to be at greater risk than women, findings indicate A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which affect parts of the body involved in reproduction and excretion—in middle ...

2025-09-17T13:29:11+00:0017 September 2025|BMJ Public Health, Press release|

Blood test for many cancers could potentially thwart progression to late stage in up to half of cases

Adding this test to usual care yearly or every two years could improve patient outcomes A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart progression to advanced disease while the malignancy is still at an early stage ...

2025-05-09T08:42:45+00:009 May 2025|BMJ Open, Press release|

BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought

May be time to reassess use of PARP inhibitor drugs in these patients, say researchers Findings pave way for refining genetic testing and personalised treatment in prostate cancer Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate ...

2025-02-25T17:36:11+00:0025 February 2025|BMJ Oncology, Press release|

Gene signature shows promise to improve survival for breast cancer patients

First trial to show feasibility of gene signature to tailor treatment for high risk patients  Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today. Triple negative breast ...

2024-10-24T11:23:53+00:0024 October 2024|Press release, The BMJ|
Go to Top